We report in this paper a robust panel of 14 metabolites associated in the SSAT-1/polyamine pathway along with other endogenous metabolites comprised of amino acids, biogenic amines, acylcarnitines and glycerophospholipids amines that correctly discriminated between lung cancer patients from healthy controls using an established and customized assay. This evidence concerns the gene SAT1 and lung carcinoma.